Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results

NEXT STORY
ADMA Biologics Reports First Quarter 2019 Financial Results
PREV STORY
Paratek’s NUZYRA™ (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytokinetics Announces Results From GALACTIC-HF Presented at Late Breaking Clinical Trial Session at the American Heart Association Scientific Sessions and Published in the New England Journal of Medicine

author_avatar
NASDAQ Market News

Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature

author_avatar
NASDAQ Market News

Orion Corporation: Managers’ transactions – Jari Karlson

author_avatar
NASDAQ Market News